Results 101 to 110 of about 2,895 (208)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease. [PDF]

Clin Transl Sci, 2022
Mason DL, Godugu K, Nnani D, Mousa SA.
europepmc   +1 more source

Serum magnesium and sudden death in European hemodialysis patients [PDF]

, 2015
Despite suggestions that higher serum magnesium (Mg) levels are associated with improved outcome, the association with mortality in European hemodialysis (HD) patients has only scarcely been investigated.
Blankestijn, P.J. (Peter), Bots, M.L. (Michiel), Brandenburg, V. (Vincent), Büchel, J. (Janine), de Roij van Zuijdewijn, C.L.M. (Camiel), Dorpel, M.A. (Marinus) van den, Groenwold, R.H.H. (Rolf H. H.), Grooteman, M.P.C. (Muriel), Nubé, M.J. (Menso), Steppan, S. (Sonja), Vervloet, M.G. (Marc), Wee, P.M. (Piet) ter   +11 more
core   +2 more sources

Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China

Therapeutics and Clinical Risk Management, 2015
Lin Meng,1,2 Bin Fu1 1Department of Nephrology, Second Affiliated Hospital to Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2Tianjin University of Traditional Chinese Medicine, Tianjin, People’s ...
Meng L, Fu B
doaj  

Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature

BMC Nephrology, 2018
Background Although fatigue is common in dialysis patients, polypharmacy is seldom listed among its causes. In this report, we describe a dialysis patient who developed severe fatigue due to pharmacological interaction between two commonly prescribed ...
Emanuela Cataldo, Valeria Columbano, Louise Nielsen, Lurlynis Gendrot, Bianca Covella, Giorgina Barbara Piccoli   +5 more
doaj   +1 more source

Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study

Cogent Medicine, 2016
Introduction: Lanthanum carbonate (LC) and sevelamer hydrochloride (SH) are non-calcium-based phosphate binders (NCPB), used to manage hyperphosphatemia in patients with chronic kidney disease.
Asrar Khan, Titi Chen, Anis Khan, Elaine Chan, Karen Byth, Jackson Tan, David Harris   +6 more
doaj   +1 more source

Calcitriol suppression of parathyroid hormone fails to improve skeletal properties in an animal model of chronic kidney disease [PDF]

, 2016
BACKGROUND: Chronic kidney disease (CKD) leads to complex metabolic changes and an increased risk of fracture. Currently, calcitriol is the standard of care as it effectively suppresses parathyroid hormone (PTH) levels in CKD patients.
Allen, Matthew R., Brown, Drew M., Chen, Neal X., Hammond, Max A., Moe, Sharon M., Newman, Christopher L., Tian, Nannan, Wallace, Joseph M.   +7 more
core   +1 more source

Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials

Kidney & Blood Pressure Research, 2018
Background/Aims: Hyperphosphatemia is common in patients on hemodialysis. The efficacy of lanthanum carbonate (LC) in the treatment of hyperphosphatemia in these patients remains controversial.
Fang Wang, Xiangxue  Lu, Jingli Zhang, Ruifang Xiong, Han Li, Shixiang Wang   +5 more
doaj   +1 more source

The impact of sevelamer in aluminum phosphide poisoning: a preliminary study on mortality

Medicina Clínica Práctica
Background: Aluminum phosphide (ALP) poisoning, commonly referred to as rice tablet poisoning, is among the deadliest forms of poisoning. Treatment for aluminum phosphide poisoning is limited to supportive care, as no specific antidote is currently ...
Kiandokht Khorshidi, Maral Ramezani, Mitra Rahimi, Shahin Shadnia, Babak Mostafazadeh, Peyman Erfan Talab Evini   +5 more
doaj   +1 more source

Iron parameters in patients with end-stage renal disease receiving lanthanum carbonate or other non-iron-based phosphate binders: Results from a phase 3, randomized open-label study

SAGE Open Medicine, 2018
Objectives: The recent availability of iron-based phosphate binders has raised some concerns about iron overload in patients with end-stage renal disease.
Rosamund J Wilson, Beverly Jones, Claudio Marelli   +2 more
doaj   +1 more source

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword [PDF]

, 2017
The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) represents a selective update of the ...
Wheeler, DC, Winkelmayer, WC
core